BSX vs HBANP · P/E 20, rev $20.07B vs P/E 23
Boston Scientific Corp (BSX) versus Huntington Bancshares Incorporated (HBANP) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Huntington Bancshares Incorporated (HBANP) is a banks - regional company listed on US.
Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
HBANP does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. HBANP currently screens at market cap $0 and trailing P/E 22.8.
Not investment advice. Open the BSX and HBANP stock pages for the full models.
Not investment advice.